Intellia Therapeutics, Inc. (NTLA) - Risk-Adjusted Returns & Sharpe Ratio | pfolio
Intellia Therapeutics, Inc. (NTLA): 1Y return 103.0%, Sharpe ratio 1.22, volatility 97.5%, max drawdown -71.3%. A Stock in the Equity asset class. Compare NTLA with other assets and invest through your own broker with pfolio.
Intellia Therapeutics, Inc. (NTLA) Overview
- Type: Stock
- Asset Class: Equity
- Region: Americas
- Country: US (Developed)
- Currency: USD
NTLA Performance
- MTD
- Return: 16.5%, Sharpe: 9.65, Volatility: 37.2%, Max Drawdown: -2.7%
- YTD
- Return: 66.2%, Sharpe: 2.62, Volatility: 76.2%, Max Drawdown: -30.3%
- 1Y
- Return: 103.0%, Sharpe: 1.22, Volatility: 97.5%, Max Drawdown: -71.3%
- 5Y
- Return: -80.0%, Sharpe: 0.00, Volatility: 79.0%, Max Drawdown: -96.4%
Frequently Asked Questions
- What is Intellia Therapeutics, Inc. (NTLA)?
- Intellia Therapeutics, Inc. (NTLA) is a Stock in the Equity asset class. pfolio shows its cumulative return, volatility, Sharpe ratio, and max drawdown across MTD, YTD, 1Y, 5Y, 10Y, 20Y, and all-time periods.
- How does NTLA compare to other assets?
- You can compare NTLA with any other asset using pfolio's comparison tool, which ranks assets side-by-side by risk-adjusted returns.
- Can I invest in NTLA through pfolio?
- pfolio helps you build diversified portfolios that may include NTLA. You invest through your own broker — pfolio provides the analytics.